4
Changes in Ownership
Solid Biosciences Inc. Filed Acc 0001193125-26-034087
President and CEO sold 80,258 shares at $6.44 ($516,613)
- President and CEO acquired 269,801 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cumbo Alexander President and CEO | 2026-01-29 | Option exercise 10b5-1 | +169,401 | 250,789 | D | ||
| Cumbo Alexander President and CEO | 2026-01-31 | Option exercise 10b5-1 | +100,400 | 351,189 | D | ||
| Cumbo Alexander President and CEO | 2026-02-02 | Sale 10b5-1 | −80,258 | $6.44 | $516,613 | 270,931 | D |
| Derivatives | |||||||
| Cumbo Alexander President and CEO | 2026-01-29 | Option exercise · Performance Stock Units 10b5-1 | −169,401 | 0 | D | ||
| Cumbo Alexander President and CEO | 2026-01-29 | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +509,850 | 509,850 | D | ||
| Cumbo Alexander President and CEO | 2026-01-29 | Grant or award · Restricted Stock Units 10b5-1 | +254,900 | 254,900 | D | ||
| Cumbo Alexander President and CEO | 2026-01-31 | Option exercise · Restricted Stock Units 10b5-1 | −100,400 | 301,200 | D | ||
| Open-market sales · 80,258 sh · avg $6.44 · $516,613 | |||||||
Loading xslF345X05/ownership.xml…